{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:59:59Z","timestamp":1758448799322,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.metabol.2008.06.010","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T04:06:38Z","timestamp":1225166798000},"page":"1552-1557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone"],"prefix":"10.1016","volume":"57","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibilla A.T.","family":"Salvadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fogari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2008.06.010_bib1","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2007.03.052","article-title":"The epidemiology of obesity","volume":"132","author":"Ogden","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2008.06.010_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1024\/0300-9831.76.4.172","article-title":"From obesity to diabetes","volume":"76","author":"Keller","year":"2006","journal-title":"Int J Vitam Nutr Res"},{"issue":"S1","key":"10.1016\/j.metabol.2008.06.010_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/diacare.27.2007.S36","article-title":"Nutrition principles and recommendations in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.metabol.2008.06.010_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diacare.27.2007.S58","article-title":"Physical activity\/exercise and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2008.06.010_bib5","doi-asserted-by":"crossref","first-page":"68B","DOI":"10.1016\/j.amjcard.2006.11.007","article-title":"Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction","volume":"99","author":"Lee","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2008.06.010_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2008.06.010_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1463-1326.2006.00622.x","article-title":"Weight gain in type 2 diabetes mellitus","volume":"9","author":"Jacob","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2008.06.010_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/dc06-1962","article-title":"The effect of beta-adrenergic and peroxisome proliferator\u2013activated receptor\u2013gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue","volume":"30","author":"Bogacka","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2008.06.010_bib9","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.2337\/dc07-S048","article-title":"Nutrition recommendations and principles for people with diabetes mellitus: a position statement of American Diabetes Association","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl","key":"10.1016\/j.metabol.2008.06.010_bib10","first-page":"S21","article-title":"Screening for diabetes (position statement)","volume":"24","author":"American Diabetes Association","year":"2001","journal-title":"Diabetes Care"},{"year":"1997","series-title":"Obesity: preventing and managing the global epidemic. Report of WHO consultation on obesity","author":"World Health Organization","key":"10.1016\/j.metabol.2008.06.010_bib11"},{"key":"10.1016\/j.metabol.2008.06.010_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2710.2006.00756.x","article-title":"Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional risk factors plasma level in type 2 diabetic patients with metabolic syndrome","volume":"31","author":"Derosa","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.metabol.2008.06.010_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1445-5994.2007.01238.x","article-title":"Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin","volume":"37","author":"Derosa","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.metabol.2008.06.010_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2008.06.010_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"year":"1971","series-title":"Statistical principles in experimental design","author":"Winer","key":"10.1016\/j.metabol.2008.06.010_bib16"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2008.06.010_bib17","first-page":"116S","article-title":"Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options","volume":"10","author":"Fujioka","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2008.06.010_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2008.06.010_bib19","first-page":"222","article-title":"Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients","volume":"17","author":"Derosa","year":"2004","journal-title":"Diabetes Nutr Metab"},{"key":"10.1016\/j.metabol.2008.06.010_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1291\/hypres.30.23","article-title":"Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes","volume":"30","author":"Eguchi","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2008.06.010_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/147323000603400513","article-title":"Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome","volume":"34","author":"Derosa","year":"2006","journal-title":"J Int Med Res"},{"key":"10.1016\/j.metabol.2008.06.010_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.STR.0000257974.06317.49","article-title":"Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)","volume":"38","author":"Wilcox","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2008.06.010_bib23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1517\/14656566.8.12.1985","article-title":"Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects","volume":"8","author":"Pfutzner","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2008.06.010_bib24","first-page":"1307","article-title":"Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias","volume":"166","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.metabol.2008.06.010_bib25","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation","volume":"106","author":"Birkenfeld","year":"2002","journal-title":"Circulation"},{"issue":"Suppl 4","key":"10.1016\/j.metabol.2008.06.010_bib26","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/sj.ijo.0802218","article-title":"Sibutramine and its cardiovascular profile","volume":"26","author":"Narkiewicz","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2008.06.010_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2004.00372.x","article-title":"Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients","volume":"7","author":"Derosa","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2008.06.010_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","article-title":"Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by betaadrenergic blocking agents: a placebo-controlled, double-blind, randomised trial","volume":"16","author":"Sramek","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.metabol.2008.06.010_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.jhh.1001298","article-title":"Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors","volume":"16","author":"McMahon","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.metabol.2008.06.010_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1185\/030079907X199691","article-title":"A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies","volume":"23","author":"Barnett","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.metabol.2008.06.010_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MED.0b013e3282f79b20","article-title":"Glitazones and the cardiovascular system","volume":"15","author":"Devchand","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.metabol.2008.06.010_bib32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2165\/00003495-200363130-00004","article-title":"Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence","volume":"63","author":"Diamant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2008.06.010_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/13543784.12.7.1179","article-title":"Thiazolidinediones\u2014some recent developments","volume":"12","author":"Stumvoll","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.metabol.2008.06.010_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1291\/hypres.30.387","article-title":"Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin","volume":"30","author":"Derosa","year":"2007","journal-title":"Hypertens Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950800231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950800231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:29:36Z","timestamp":1758425376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604950800231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S002604950800231X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2008.06.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2008.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}